Literature DB >> 21454873

Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis.

Luis Escribano, Ivan Alvarez-Twose, Andres Garcia-Montero, Laura Sanchez-Muñoz, Maria Jara-Acevedo, Alberto Orfao.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21454873      PMCID: PMC3069249          DOI: 10.3324/haematol.2011.040865

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis.

Authors:  Roberta Zanotti; Patrizia Bonadonna; Massimiliano Bonifacio; Anna Artuso; Donatella Schena; Maurizio Rossini; Omar Perbellini; Sabrina Colarossi; Marco Chilosi; Giovanni Pizzolo
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

2.  Clinical advances in mastocytosis: an interdisciplinary roundtable discussion. Southampton, Bermuda, June 15, 1990.

Authors: 
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

3.  Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.

Authors:  Patrizia Bonadonna; Omar Perbellini; Giovanni Passalacqua; Beatrice Caruso; Sabrina Colarossi; Daniela Dal Fior; Luca Castellani; Chiara Bonetto; Francesco Frattini; Annarita Dama; Giovanni Martinelli; Marco Chilosi; Gianenrico Senna; Giovanni Pizzolo; Roberta Zanotti
Journal:  J Allergy Clin Immunol       Date:  2009-01-09       Impact factor: 10.793

4.  Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

Authors:  Iván Alvarez-Twose; David González de Olano; Laura Sánchez-Muñoz; Almudena Matito; Maria I Esteban-López; Arantza Vega; Maria Belén Mateo; Maria D Alonso Díaz de Durana; Belén de la Hoz; Maria D Del Pozo Gil; Teresa Caballero; Ana Rosado; Isabel Sánchez Matas; Cristina Teodósio; María Jara-Acevedo; Manuela Mollejo; Andrés García-Montero; Alberto Orfao; Luis Escribano
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

Review 5.  Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

Authors:  P Valent; C Akin; L Escribano; M Födinger; K Hartmann; K Brockow; M Castells; W R Sperr; H C Kluin-Nelemans; N A T Hamdy; O Lortholary; J Robyn; J van Doormaal; K Sotlar; A W Hauswirth; M Arock; O Hermine; A Hellmann; M Triggiani; M Niedoszytko; L B Schwartz; A Orfao; H-P Horny; D D Metcalfe
Journal:  Eur J Clin Invest       Date:  2007-06       Impact factor: 4.686

6.  Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

Authors:  Luis Escribano; Iván Alvarez-Twose; Laura Sánchez-Muñoz; Andres Garcia-Montero; Rosa Núñez; Julia Almeida; Maria Jara-Acevedo; Cristina Teodósio; Mónica García-Cosío; Carmen Bellas; Alberto Orfao
Journal:  J Allergy Clin Immunol       Date:  2009-07-09       Impact factor: 10.793

  6 in total
  1 in total

Review 1.  Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis.

Authors:  Oscar González-López; Javier I Muñoz-González; Alberto Orfao; Iván Álvarez-Twose; Andrés C García-Montero
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.